225Research

225Research strives to find strong investment opportunities and aims to provide in-depth and insightful analysis of these opportunities for our readers.

April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  

Disclaimer

The information found on “The Stock Boys” is for informational purposes only. It should not be taken or used as financial advice. The Stock Boys makes no guarantee or promises as to any results that may be obtained from using our content. No one should make any investment decision based solely on the information found on this site and without the help of a financial adviser or conduction of their own research and due diligence. The Stock Boys disclaim any liability for any results incurred by the use of our information, content or articles. Your use of the information of materials linked from the site is at your own risk.

April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  

Disclaimer

The information found on “The Stock Boys” is for informational purposes only. It should not be taken or used as financial advice. The Stock Boys makes no guarantee or promises as to any results that may be obtained from using our content. No one should make any investment decision based solely on the information found on this site and without the help of a financial adviser or conduction of their own research and due diligence. The Stock Boys disclaim any liability for any results incurred by the use of our information, content or articles. Your use of the information of materials linked from the site is at your own risk.

Year: 2019

Charts to Watch – September 23-27

S & P Global (SPGI) S&P has continued to show strength since the bottom during last December, and has shown no signs of breaking its uptrend. we may see a little bit of consolidation as valuation catches up to the…

Charts to watch- September 16th- 21st

Bausch health (BHC.TO, BHC) Bausch health is looking very interesting with what looks like to be an inverse head and shoulder pattern building on the longer term chart. the base its building is looking very strong, and a breakout of…

TransDigm Inc and The Power of Pricing

TDG Symbol Info by TradingView About TransDigm Group: TransDigm Group is a market-leading manufacturer of proprietary aerospace components, headquartered in Cleveland, Ohio. They focus on highly engineered aviation parts, operating in three specialized segments within the industry: power & control,…

Charts to Watch- September 9th- September 13th

Church & Dwight (CHD) Simple enough, the name is still making new highs and is indicating relative outperformance vs the S&P. At the lower end of the rising Channel is a good time to get in, especially with the main…

Charts to watch- September 2- 6th

Heroux-Devtek (HRX on the TSX) HRX looks to bouncing off a tread-line of support with a strong Hammer candle indicating buyers appearing to keep the uptrend intact. The 200 MA is acting strong here as well, as another indicator that…

Energy Stocks- Dividend sustainability/growth for 4 High Payers

With many energy stocks trading at 52 week lows, it’s only fitting that yields have skyrocketed with the inverse relationship with yields rising as share prices fall. This means that investors have been able to get 7%+ yields everywhere in…

Breaking up Alphabet, good for investors?

Alphabet shares two titles, both considered bad news; it is underperforming the broader markets year to date, even though it’s considered a forerunner in tech and part of the FAANG group. The second title is the title of most likely…

North American Palladium – in short supply so to the sky?

Catching a large bid early on in the year due to skyrocketing palladium prices, North American Palladium (PDL on the TSX) has pulled back and looks poised to go on another run, as palladium prices continue their move higher.  North…

Bausch Health

Download the full Bausch Health Report Bausch Health (formerly known as Valeant) is a Canadian based company headquartered in Laval Quebec. The company we know today was a direct result of a series of acquisitions, cutting R&D, and raising prices…